Pablo Sanchez, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck Sharpe & Dome
    Topic:
    RSV Clesrovimab
    Date added:
    05/31/2026
    Date updated:
    05/31/2026
    Relationship end date:
    05/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Kamada Pharmaceuticals
    Topic:
    CMV IVIG
    Date added:
    05/31/2026
    Date updated:
    05/31/2026
    Relationship end date:
    12/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    CyanVac
    Topic:
    Vaccination
    Date added:
    05/31/2026
    Date updated:
    05/31/2026
    Relationship end date:
    06/05/2026
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck
    Topic:
    Pneumococcal vaccination
    Date added:
    05/31/2026
    Date updated:
    05/31/2026
    Relationship end date:
    03/19/2026
Return to 2026 KY Early Hearing Detection & Intervention Summit